Asthma in Children Clinical Practice Guidelines (ERS, 2021)

European Respiratory Society

These are some of the highlights of the guidelines without analysis or commentary. For more information, go directly to the guidelines by clicking the link in the reference.

December 03, 2021

Guidelines for the diagnosis of asthma in children aged 5–16 years were published in November 2021 by the European Respiratory Society (ERS) in European Respiratory Journal.[1]

Spirometry is recommended as part of the diagnostic workup of children aged 5–16 years with suspected asthma.

Bronchodilator reversibility (BDR) testing is recommended in all children with FEV1 < LLN or < 80% pred and/or FEV1/FVC < LLN or < 80%.

Measurement of exhaled nitric oxide (F eNO) is recommended as part of the diagnostic workup of children aged 5–16 years with suspected asthma.

Diagnosing asthma in children based on clinical history alone or following a single abnormal objective test is not recommended.

PEFR variability testing as the primary objective test on its own to diagnose asthma in children aged 5–16 years is not recommended.

A direct bronchial challenge test using methacholine is recommended in children aged 5–16 years under investigation for asthma where asthma diagnosis could not be confirmed with first-line objective tests.

For more information, go to Pediatric Asthma.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....